Disability and disability-adjusted life years: not the same.
作者信息
Grosse Scott D, Lollar Donald J, Campbell Vincent A, Chamie Mary
机构信息
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
出版信息
Public Health Rep. 2009 Mar-Apr;124(2):197-202. doi: 10.1177/003335490912400206.
Abstract
摘要
相似文献
1
Disability and disability-adjusted life years: not the same.
Public Health Rep. 2009 Mar-Apr;124(2):197-202. doi: 10.1177/003335490912400206.
2
Assessing the burden of disease in the United States using disability-adjusted life years.
Am J Prev Med. 2005 Jun;28(5):415-23. doi: 10.1016/j.amepre.2005.02.009.
3
[The International Classification of Functioning, Disability and Health].
Nervenarzt. 2005 Jan;76(1):79-90; quiz 91-2. doi: 10.1007/s00115-004-1855-8.
4
Disability Adjusted Life Years (DALYs) and rehabilitation.
Disabil Rehabil. 2002 May 10;24(7):378-82. doi: 10.1080/09638280110096269.
5
The global burden of epilepsy.
Epilepsia. 2002;43 Suppl 6:21-5. doi: 10.1046/j.1528-1157.43.s.6.11.x.
6
An overview of disability.
Br J Rheumatol. 1996 Feb;35(2):184-7. doi: 10.1093/rheumatology/35.2.184.
7
Personal perception and personal factors: incorporating health-related quality of life into the International Classification of Functioning, Disability and Health.
Disabil Rehabil. 2010;32(23):1955-65. doi: 10.3109/09638281003797414.
8
Measuring health burden without discriminating against the disabled.
J Public Health (Oxf). 2017 Sep 1;39(3):633-639. doi: 10.1093/pubmed/fdw072.
9
Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study.
Lancet. 1997 May 10;349(9062):1347-52. doi: 10.1016/S0140-6736(96)07494-6.
10
Describing functioning, disability, and health with the International Classification of Functioning, Disability, and Health Brief Core Set for Stroke.
Am J Phys Med Rehabil. 2012 Feb;91(13 Suppl 1):S14-21. doi: 10.1097/PHM.0b013e31823d4ba9.
引用本文的文献
1
Quality of Life, Disability, and Fungal Neglected Tropical Diseases.
Curr Fungal Infect Rep. 2025 Apr;19(1). doi: 10.1007/s12281-025-00503-0.
2
A Community-Based Survivorship Model for Individuals With Orthopedic Disabilities in Rural Areas.
Cureus. 2025 Jul 14;17(7):e87887. doi: 10.7759/cureus.87887. eCollection 2025 Jul.
3
Economic evaluation of caregiver interventions for children with developmental disabilities: A scoping review.
PLOS Glob Public Health. 2025 Jun 30;5(6):e0003928. doi: 10.1371/journal.pgph.0003928. eCollection 2025.
4
Burden attributable to Iodine deficiency in Iran from 1990 to 2019: findings from Global Burden of Disease study.
J Prev Med Hyg. 2025 Jan 31;65(4):E524-E531. doi: 10.15167/2421-4248/jpmh2024.65.4.3271. eCollection 2024 Dec.
5
Disability-adjusted life years due to COVID-19 in Sri Lanka: a retrospective cross-sectional study.
BMJ Public Health. 2023 Jun 30;1(1):e000055. doi: 10.1136/bmjph-2023-000055. eCollection 2023 Nov.
6
Doubly Marginalized: The Interplay of Racism and Disability in Outcomes for Minoritized People With Down Syndrome.
Epidemiology. 2025 Jan 1;36(1):66-75. doi: 10.1097/EDE.0000000000001789. Epub 2024 Sep 24.
7
A systematic review of studies that estimated the burden of chronic non-communicable rare diseases using disability-adjusted life years.
Orphanet J Rare Dis. 2024 Sep 9;19(1):333. doi: 10.1186/s13023-024-03342-3.
8
GBD2021: headache disorders and global lost health - a focus on children, and a view forward.
J Headache Pain. 2024 Jun 3;25(1):91. doi: 10.1186/s10194-024-01795-2.
9
The burdens attributable to primary headache disorders in children and adolescents in Iran: estimates from a schools-based study.
J Headache Pain. 2024 May 27;25(1):86. doi: 10.1186/s10194-024-01789-0.
10
Chronic conditions in women: the development of a National Institutes of health framework.
BMC Womens Health. 2023 Apr 6;23(1):162. doi: 10.1186/s12905-023-02319-x.
本文引用的文献
1
Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti.
PLoS Med. 2007 May;4(5):e183. doi: 10.1371/journal.pmed.0040183.
2
Measuring health and disability.
Lancet. 2007 May 12;369(9573):1658-63. doi: 10.1016/S0140-6736(07)60752-1.
3
Response shift theory: important implications for measuring quality of life in people with disability.
Arch Phys Med Rehabil. 2007 Apr;88(4):529-36. doi: 10.1016/j.apmr.2006.12.032.
4
Why invest in a national public health program for stroke? An example using Australian data to estimate the potential benefits and cost implications.
Health Policy. 2007 Oct;83(2-3):287-94. doi: 10.1016/j.healthpol.2007.02.001. Epub 2007 Mar 21.
5
Cost-effectiveness of a folic acid fortification program in Chile.
Health Policy. 2007 Oct;83(2-3):295-303. doi: 10.1016/j.healthpol.2007.01.011. Epub 2007 Mar 23.
6
Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis.
Lancet. 2007 Feb 3;369(9559):389-96. doi: 10.1016/S0140-6736(07)60195-0.
7
The burden of disease and injury in the United States 1996.
Popul Health Metr. 2006 Oct 18;4:11. doi: 10.1186/1478-7954-4-11.
8
Calculating QALYs, comparing QALY and DALY calculations.
Health Policy Plan. 2006 Sep;21(5):402-8. doi: 10.1093/heapol/czl018. Epub 2006 Jul 28.
9
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.
Lancet. 2006 May 27;367(9524):1747-57. doi: 10.1016/S0140-6736(06)68770-9.
10
Health burden and funding at the Centers for Disease Control and Prevention.
Am J Prev Med. 2006 Mar;30(3):269-76. doi: 10.1016/j.amepre.2005.10.028.
Zotero 插件